Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Mirvetuximab soravtansine 6, Ovarian Carcinoma

Protocol-ID: 2606 V1.0 (Mini), MIRSOR6, Ovarian Ca

Indication(s)

  • Ovarian Tumor (Folate receptor alpha positive); ICD-10 C56

Links

  • Prescribing information for mirvetuximab soravtansine (ELAHERE) [URL]
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 30.05.2024